{"id":58490,"date":"2021-01-22T10:31:02","date_gmt":"2021-01-22T09:31:02","guid":{"rendered":"https:\/\/www.iccas.de\/?p=58490"},"modified":"2021-05-31T09:49:43","modified_gmt":"2021-05-31T07:49:43","slug":"iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen","status":"publish","type":"post","link":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/?&lang=en","title":{"rendered":"ICCAS leads platform development to support therapy decisions in complex blood cancers"},"content":{"rendered":"

Janssen Germany aims to improve the treatment of blood cancer through the use of artificial intelligence (AI). To this end, the research-focused pharmaceutical company supports a research project in which ICCAS and the Clinic for Hematology Cell Therapy and Hemostaseology at Leipzig University Hospital serve as the leading technology partners. Together they are pursuing the goal of developing an AI-based digital health platform for therapeutic decision support for patients with complex blood disorders. The KAIT platform will be accessible to physicians in clinics and practices and provide them with evidence-based suggestions for individualized therapy strategies. In three years the KAIT platform will be available as a reliable and practical tool to support clinical routines.<\/p>\n

Press release (available in German)<\/a>
\nLink to project website (German)<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Janssen Germany aims to improve the treatment of blood cancer through the use of artificial intelligence (AI).<\/p>\n","protected":false},"author":31,"featured_media":58491,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-58490","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"acf":[],"yoast_head":"\nICCAS leads platform development to support therapy decisions in complex blood cancers - Innovation Center Computer Assisted Surgery<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/?&lang=en\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:locale:alternate\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ICCAS leads platform development to support therapy decisions in complex blood cancers\" \/>\n<meta property=\"og:description\" content=\"Janssen Germany aims to improve the treatment of blood cancer through the use of artificial intelligence (AI).\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/\" \/>\n<meta property=\"og:site_name\" content=\"Innovation Center Computer Assisted Surgery\" \/>\n<meta property=\"article:published_time\" content=\"2021-01-22T09:31:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-05-31T07:49:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"345\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Editor\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Editor\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/\"},\"author\":{\"name\":\"Editor\",\"@id\":\"https:\/\/www.iccas.de\/#\/schema\/person\/d3c71311370df3dc619869b2ff907578\"},\"headline\":\"ICCAS leads platform development to support therapy decisions in complex blood cancers\",\"datePublished\":\"2021-01-22T09:31:02+00:00\",\"dateModified\":\"2021-05-31T07:49:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/\"},\"wordCount\":270,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg\",\"articleSection\":[\"News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/\",\"url\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/\",\"name\":\"ICCAS leads platform development to support therapy decisions in complex blood cancers\",\"isPartOf\":{\"@id\":\"https:\/\/www.iccas.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg\",\"datePublished\":\"2021-01-22T09:31:02+00:00\",\"dateModified\":\"2021-05-31T07:49:43+00:00\",\"author\":{\"@id\":\"https:\/\/www.iccas.de\/#\/schema\/person\/d3c71311370df3dc619869b2ff907578\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage\",\"url\":\"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg\",\"contentUrl\":\"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg\",\"width\":1280,\"height\":345},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.iccas.de\/?&lang=en\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ICCAS leads platform development to support therapy decisions in complex blood cancers\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.iccas.de\/#website\",\"url\":\"https:\/\/www.iccas.de\/\",\"name\":\"Innovation Center Computer Assisted Surgery\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.iccas.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.iccas.de\/#\/schema\/person\/d3c71311370df3dc619869b2ff907578\",\"name\":\"Editor\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.iccas.de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/24b6ff9ace8fa79e21be166258d4d5bdc4dc1b729722c902c807482ea7aec6e8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/24b6ff9ace8fa79e21be166258d4d5bdc4dc1b729722c902c807482ea7aec6e8?s=96&d=mm&r=g\",\"caption\":\"Editor\"},\"url\":\"https:\/\/www.iccas.de\/en\/author\/editor\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ICCAS leads platform development to support therapy decisions in complex blood cancers - Innovation Center Computer Assisted Surgery","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/?&lang=en","og_locale":"en_US","og_type":"article","og_title":"[:en]ICCAS leads platform development to support therapy decisions in complex blood cancers[:de]ICCAS entwickelt Plattform zur Unterst\u00fctzung von Therapieentscheidungen bei Blutkrebserkrankungen[:] - Innovation Center Computer Assisted Surgery","og_description":"Janssen Germany aims to improve the treatment of blood cancer through the use of artificial intelligence (AI).","og_url":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/","og_site_name":"Innovation Center Computer Assisted Surgery","article_published_time":"2021-01-22T09:31:02+00:00","article_modified_time":"2021-05-31T07:49:43+00:00","og_image":[{"width":1280,"height":345,"url":"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg","type":"image\/jpeg"}],"author":"Editor","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Editor","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#article","isPartOf":{"@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/"},"author":{"name":"Editor","@id":"https:\/\/www.iccas.de\/#\/schema\/person\/d3c71311370df3dc619869b2ff907578"},"headline":"ICCAS leads platform development to support therapy decisions in complex blood cancers","datePublished":"2021-01-22T09:31:02+00:00","dateModified":"2021-05-31T07:49:43+00:00","mainEntityOfPage":{"@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/"},"wordCount":270,"commentCount":0,"image":{"@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg","articleSection":["News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/","url":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/","name":"ICCAS leads platform development to support therapy decisions in complex blood cancers","isPartOf":{"@id":"https:\/\/www.iccas.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage"},"image":{"@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg","datePublished":"2021-01-22T09:31:02+00:00","dateModified":"2021-05-31T07:49:43+00:00","author":{"@id":"https:\/\/www.iccas.de\/#\/schema\/person\/d3c71311370df3dc619869b2ff907578"},"breadcrumb":{"@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#primaryimage","url":"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg","contentUrl":"https:\/\/www.iccas.de\/wp-content\/uploads\/2021\/01\/KAIT-logo.jpg","width":1280,"height":345},{"@type":"BreadcrumbList","@id":"https:\/\/www.iccas.de\/en\/iccas-entwickelt-plattform-zur-unterstuetzung-von-therapieentscheidungen-bei-blutkrebserkrankungen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.iccas.de\/?&lang=en"},{"@type":"ListItem","position":2,"name":"ICCAS leads platform development to support therapy decisions in complex blood cancers"}]},{"@type":"WebSite","@id":"https:\/\/www.iccas.de\/#website","url":"https:\/\/www.iccas.de\/","name":"Innovation Center Computer Assisted Surgery","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.iccas.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.iccas.de\/#\/schema\/person\/d3c71311370df3dc619869b2ff907578","name":"Editor","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.iccas.de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/24b6ff9ace8fa79e21be166258d4d5bdc4dc1b729722c902c807482ea7aec6e8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/24b6ff9ace8fa79e21be166258d4d5bdc4dc1b729722c902c807482ea7aec6e8?s=96&d=mm&r=g","caption":"Editor"},"url":"https:\/\/www.iccas.de\/en\/author\/editor\/"}]}},"_links":{"self":[{"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/posts\/58490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/users\/31"}],"replies":[{"embeddable":true,"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/comments?post=58490"}],"version-history":[{"count":10,"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/posts\/58490\/revisions"}],"predecessor-version":[{"id":58835,"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/posts\/58490\/revisions\/58835"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/media\/58491"}],"wp:attachment":[{"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/media?parent=58490"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/categories?post=58490"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.iccas.de\/en\/wp-json\/wp\/v2\/tags?post=58490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}